Extended-Release Calcifediol for Secondary Hyperparathyroidism 
in Stage 3-4 Chronic Kidney Disease.

Expert Rev Endocrinol Metab 2017

Use of Extended-Release Calcifediol to Treat Secondary Hyperparathyroidism
in Stages 3 and 4 Chronic Kidney Disease.

Am J Nephrol. 2016;44(4):316-325. Epub 2016 Sep 28.

Extended-Release Calcifediol Found Safe, Effective for SHPT
Renal & Urology News

Modified-Release Calcifediol Effectively Controls Secondary Hyperparathyroidism
Associated with Vitamin D Insufficiency in Chronic Kidney Disease

Am J Nephrol 2014;40:535–545

Modified-release oral calcifediol corrects vitamin D insufficiency
with minimal CYP24A1 upregulation

Journal of Steroid Biochemistry & Molecular Biology (2015)


© 2017 OPKO Health Inc.- All rights reserved. | Privacy Policy | Terms Of Use